Of note, an altered kinase signaling network involving EGFR, PDGFR, PAK1, PTK2 (FAK), PRKCD, and MAP2K2 appear to regulate the aberrant changes in the cancer cells and the TME accompanying recurrence. This evidence concerns the gene PDGFRB and cancer.